Keywords: مرحله دوم; Alzheimer's disease; Phase I; Phase II; Phase III; Biomarkers; Preclinical AD; Prodromal AD; AD dementia;
مقالات ISI مرحله دوم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مرحله دوم; First-line treatment; Kidney cancer; mRCC; Phase II; VEGFR inhibitor;
Keywords: مرحله دوم; Androgen-deprivation therapy; Docetaxel; Estrogen; Phase II; PSA;
Keywords: مرحله دوم; Alzheimer's disease; Drug development; Phase I; Phase II; Phase III; Biomarkers; Amyloid; Tau; Cognitive enhancement;
Keywords: مرحله دوم; AE; adverse event; CI; confidence interval; GMT; geometric mean titer; HA; hemagglutinin; HAI; hemagglutination inhibition; IIV3; trivalent inactivated influenza vaccine; IIV3-HD; high-dose trivalent inactivated influenza vaccine; IIV3-SD; standard-dose t
Keywords: مرحله دوم; Thymic carcinoma; Invasive thymoma; Chemotherapy; Amrubicin; Phase II
Keywords: مرحله دوم; Endometrial; Cancer; Ridaforolimus; Recurrent; Metastatic; Phase II;
Keywords: مرحله دوم; Sarcoma; Soft tissue; Clinical trial; Phase II; Radiotherapy; Targeted; Brachytherapy; Radioisotope; Operative surgical procedures; Local neoplasm recurrence; Toxic potential;
Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000-10,000â¯IU/L: Phase II Open Label, Single Arm Multi-Centre Trial
Keywords: مرحله دوم; Gefitinib; Methotrexate; Ectopic pregnancy; Medical treatment; Phase II;
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
Keywords: مرحله دوم; Dalantercept; Ovarian cancer; Clinical trial; Phase II;
Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
Keywords: مرحله دوم; Chemotherapy; Cooperative group trial; KRAS; pCR; Phase II;
Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review
Keywords: مرحله دوم; Reporting; Phase II; Clinical trials; Methodology; Oncology; Literature review;
Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial
Keywords: مرحله دوم; NSCLC; Stage III; Dose escalated chemoradiotherapy; Phase II; Randomized;
Cabazitaxel Plus Lapatinib as Therapy for HER2+ Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study
Keywords: مرحله دوم; Brain metastases; CNS metastases; Human epidermal growth factor receptor 2-positive breast cancer; MBC; Phase II;
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma
Keywords: مرحله دوم; Combination Therapy; Overall response rate; Phase I; Phase II; Relapsed and refractory lymphoma;
Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m2) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
Keywords: مرحله دوم; Breast cancer; Nab-paclitaxel; Neoadjuvant chemotherapy; Peripheral neuropathy; Phase II;
Enhancement of TCE removal by a static magnetic field in a fungal biotrickling filter
Keywords: مرحله دوم; BTF; biotrickling filter; MF; magnetic field; MFI; magnetic field intensities; TCE; trichloroethylene; EC; elimination capacity; RE; removal efficiency; ILR; inlet loading rate; Phase I; Start-up; Phase II; MFI 0â¯mT; Phase III; MFI 20.0â¯mT; Phase IV;
A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group
Keywords: مرحله دوم; Mesothelioma; Angiogenesis; Fibroblast growth factor receptor; Phase II;
Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer
Keywords: مرحله دوم; Clinical trial; Phase II; Ovarian cancer; Bevacizumab; Irinotecan;
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen
Keywords: مرحله دوم; PIKA adjuvant; Rabies vaccine; Immunogenicity; Safety; TLR3; Phase II; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CIRB; Centralised Institutional Review Board; CSIRO; Commonwealth Scientific and Industr
A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
Keywords: مرحله دوم; Myelofibrosis; Histone deacetylase inhibitor; Panobinostat; Epigenetics; Phase II;
Clinical TrialA multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study
Keywords: مرحله دوم; Thyroid carcinoma; Sunitinib; Phase II;
Phase II clinical trials of anti-amyloid β antibodies: When is enough, enough?
Keywords: مرحله دوم; Alzheimer's disease; Clinical trials; Pharmacology; Phase II; Phase III; Monoclonal antibodies; Amyloid β; Investment;
Clinical TrialIntracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study
Keywords: مرحله دوم; Glioblastoma; CpG-ODN; CpG-28; TLR9; Phase II;
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study
Keywords: مرحله دوم; IL23; IL22; Clinical Trial; Phase II; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; IL; interleukin; IRB; Institutional Review Board; TNF; tumor necrosis factor;
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
Keywords: مرحله دوم; Olaparib; Ovarian cancer; BRCA1/2 mutation; Phase II;
Original StudyA Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma
Keywords: مرحله دوم; Bladder cancer; Chemotherapy; Docetaxel; Phase II; Second-line; Urothelial carcinoma;
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Keywords: مرحله دوم; DLBCL; Syk inhibitor; B-cell receptor; Phase II; Clinical trial;
Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial
Keywords: مرحله دوم; First line treatment for breast cancer; HER2-negative breast cancer; Metastatic breast cancer; Phase I; Phase II;
A Novel Hypoxia-Inducible FactorâProlyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial
Keywords: مرحله دوم; Erythropoietin (EPO); hypoxia-inducible factor (HIF); prolyl hydroxylase inhibitor (PHI); hemoglobin response rate; pharmacokinetics; pharmacodynamics; dosing; erythropoiesis-stimulating agent (ESA); hemoglobin; reticulocyte count; hepcidin; chronic kidne
Monitoring simple linear profiles in multistage processes by a MaxEWMA control chart
Keywords: مرحله دوم; Statistical process control; Multistage processes; Simple linear profiles; MaxEWMA control scheme; Phase II
An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients
Keywords: مرحله دوم; Pasireotide; Everolimus; Prostate cancer; Castrate-resistant; Phase II;
Pressure dependence of the Raman frequencies for the modes I, II and III at constant temperatures in phase II of benzene
Keywords: مرحله دوم; Raman frequencies; Phase II; Benzene
A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)
Keywords: مرحله دوم; Non-squamous non-small-cell lung cancer; Bevacizumab; Docetaxel; S-1; Second-line; Phase II;
Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: A Southern China Urology Cancer Consortium Trial
Keywords: مرحله دوم; Pazopanib; Metastatic renal cell carcinoma; Phase II; Delta-like ligand 4; Hypoxia-inducible factor;
A Neoadjuvant, Randomized, Open-Label Phase II Trial of Afatinib Versus Trastuzumab Versus Lapatinib in Patients With Locally Advanced HER2-Positive Breast Cancer
Keywords: مرحله دوم; Anti-HER2 monoclonal antibody; EGFR tyrosine kinase inhibitor; ErbB family blocker; Locally advanced breast cancer; Phase II;
Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single‐Use Autoinjector: A Phase II Study
Keywords: مرحله دوم; Subcutaneous Injection; Testosterone; Autoinjector; Viscosity; Hypogonadism; Male; Clinical Trial; Phase II
Phase II Study of Bendamustine in Relapsed Chemotherapy Sensitive or Resistant Small-Cell Lung Cancer
Keywords: مرحله دوم; Bendamustine; Small-cell lung cancer; Relapsed; Refractory; Phase II
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignment
Keywords: مرحله دوم; Phase II; Direct assignment; Two interim analyses; Biomarker;
A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901)
Keywords: مرحله دوم; Amrubicin; Chemotherapy; Etoposide; Refractory; Small-cell lung cancer; Phase II;
A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia
Keywords: مرحله دوم; Endometrial cancer; Recurrence; Sunitinib; Phase II
A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer
Keywords: مرحله دوم; Pancreatic cancer; Erlotinib; Phase II
Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)
Keywords: مرحله دوم; Erlotinib; Phase II; NSCLC;
Strategies for the modulation of phase II metabolism in a series of PKCε inhibitors
Keywords: مرحله دوم; PKCε; Phase II; Metabolism; Glucuronidation; Polarity;
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study
Keywords: مرحله دوم; Paediatrics; Temozolomide; Topotecan; Phase II; Neuroblastoma;
A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide
Keywords: مرحله دوم; NSCLC; Phase II; h-TERT; Immunologic response; Clinical efficacy; HLA-A2+;
A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma
Keywords: مرحله دوم; Metastatic melanoma; Phase II; Ramucirumab
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours
Keywords: مرحله دوم; Neuroendocrine tumour; Randomised clinical trial; Chemotherapy; Capecitabine; Streptozocin; Cisplatin; Phase II
Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status
Keywords: مرحله دوم; Erlotinib; Pemetrexed; Epidermal growth factor receptor (EGFR) mutation; Non-squamous non-small cell cancer; Second-line chemotherapy; Phase II;
A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)
Keywords: مرحله دوم; Epidermal growth factor receptor (EGFR) mutations; Erlotinib; First line; Japanese patients; Non-small-cell lung cancer (NSCLC); Phase II; EGFR testing;